Tuesday's Top 10 Articles, Videos on TheStreet

NEW YORK ( TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.

6 Drug Stocks Unworthy of Biotech Bull Market
Adam Feuerstein
The biotech sector is having a party but not all stocks deserve invites. Here's a list of over-valued or undeserving biotech stocks. (Stocks include: CYTX, REGN, GALE)

Forget Old Media: It's Facebook First
Silvia Davi
Edelman's CEO discusses how Facebook has changed the game, and how it's affecting daily business in public relations and marketing.

5 Stocks Set to Soar on Bullish Earnings
Roberto Pedone
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week. (Stocks include: MITK, SNCR, AKAM)

Bank of America Will Skip a Foreclosure Deal Rally (Update 1)
Dan Freed
A deal with attorneys general won't shut the door on the bank's housing-related headache.

5 Banks Stocks That Trade at a Premium Over Wells Fargo
Shanthi Bharatwaj
TheStreet shortlisted five stocks that trade at a premium to Wells Fargo. While some stocks have been standout performers in the crisis, not all stocks might be able to justify their premium.

10 Ex-Dividend Stocks With Buy Ratings
Alexandra Zendrian
These companies, which go ex-dividend Wednesday, get buy ratings from TheStreet Ratings.

5 Stock Strategies From Wall Street: Feb 7 (Update 1)
Chao Deng
Find out what to extract from stock performance so far this year as well as what Wall Street is saying about aerospace, financials and the media sectors.

What Exactly Will Be In the Apple TV?
Chris Ciaccia
Investors are keen to hear more about the Apple TV. Here's a roundup of what the technology might offer.

3 Things That Could Move Financial Stocks Today (Update 1)
Shanthi Bharatwaj
Housing continues to be on the top of the banking sector's agenda.

Investors Should Give Cisco Another Chance
James Rogers
This time last year Cisco was the sick man of Silicon Valley. Fast forward 12 months, though, and the rejuvenated networking giant is worth a look.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case

Cytori Therapeutics Stock Sliding on Offering Price Discount

GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open

Insider Trading Alert - SUNE, NRIM And CYTX Traded By Insiders